Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Marberger

Showing results (231-240 of 250) with videos related to

Pageof 25
Sort By:
Techniques in Urology|December 7, 2000
Outcome predictors of high-energy transurethral microwave thermotherapyB Bursa, R Wammack, B Djavan, et al.
Techniques in Urology|August 24, 1999
Combination and multivariate analysis of PSA-based parameters for prostate cancer predictionB Djavan, M Remzi, A R Zlotta, et al.
Techniques in Urology|December 7, 2000
Microwave thermotherapy in patients with chronic urinary retentionB Djavan, R Wammack, K Ghawidel, et al.
Urology|February 13, 2001
Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 monthsB Djavan, C Seitz, C G Roehrborn, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: results of a phase II trialM Schmidinger, G Steger, C Wenzel, et al.
British Journal of Urology|March 6, 1998
Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancerA R Zlotta, B Djavan, C Matos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminomaW J Reiter, T Brodowicz, S Alavi, et al.
European Urology|July 15, 2000
Is one set of sextant biopsies enough to rule out prostate Cancer? Influence of transition and total prostate volumes on prostate cancer yieldB Djavan, A R Zlotta, S Ekane, et al.
Anti-Cancer Drugs|June 1, 2000
Vinorelbine and interferon-alpha2c as second-line therapy in metastatic renal cell carcinomaM Schmidinger, G G Steger, A C Budinsky, et al.
The Prostate|December 18, 2001
Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostateA Handisurya, G E Steiner, U Stix, et al.
Pageof 25

Showing results (231-240 of 250) with videos related to

Sort By:
Pageof 25
Techniques in Urology|December 7, 2000
Outcome predictors of high-energy transurethral microwave thermotherapyB Bursa, R Wammack, B Djavan, et al.
Techniques in Urology|August 24, 1999
Combination and multivariate analysis of PSA-based parameters for prostate cancer predictionB Djavan, M Remzi, A R Zlotta, et al.
Techniques in Urology|December 7, 2000
Microwave thermotherapy in patients with chronic urinary retentionB Djavan, R Wammack, K Ghawidel, et al.
Urology|February 13, 2001
Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 monthsB Djavan, C Seitz, C G Roehrborn, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 8, 2001
Sequential administration of interferon-gamma, GM-CSF, and interleukin-2 in patients with metastatic renal cell carcinoma: results of a phase II trialM Schmidinger, G Steger, C Wenzel, et al.
British Journal of Urology|March 6, 1998
Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancerA R Zlotta, B Djavan, C Matos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Twelve-year experience with two courses of adjuvant single-agent carboplatin therapy for clinical stage I seminomaW J Reiter, T Brodowicz, S Alavi, et al.
European Urology|July 15, 2000
Is one set of sextant biopsies enough to rule out prostate Cancer? Influence of transition and total prostate volumes on prostate cancer yieldB Djavan, A R Zlotta, S Ekane, et al.
Anti-Cancer Drugs|June 1, 2000
Vinorelbine and interferon-alpha2c as second-line therapy in metastatic renal cell carcinomaM Schmidinger, G G Steger, A C Budinsky, et al.
The Prostate|December 18, 2001
Differential expression of interleukin-15, a pro-inflammatory cytokine and T-cell growth factor, and its receptor in human prostateA Handisurya, G E Steiner, U Stix, et al.
Pageof 25